341 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Bought by Kestra Investment Management LLC

Kestra Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 341 shares of the company’s stock, valued at approximately $27,000.

Other hedge funds have also modified their holdings of the company. Allspring Global Investments Holdings LLC raised its holdings in Prestige Consumer Healthcare by 3.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock worth $126,274,000 after buying an additional 49,331 shares during the period. Geode Capital Management LLC increased its position in shares of Prestige Consumer Healthcare by 4.0% in the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock worth $95,678,000 after acquiring an additional 50,961 shares in the last quarter. Congress Asset Management Co. raised its holdings in shares of Prestige Consumer Healthcare by 5.0% during the fourth quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock valued at $70,964,000 after acquiring an additional 43,619 shares during the period. Boston Trust Walden Corp lifted its position in shares of Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock valued at $64,942,000 after acquiring an additional 252,089 shares in the last quarter. Finally, Eagle Asset Management Inc. lifted its position in shares of Prestige Consumer Healthcare by 0.7% in the 3rd quarter. Eagle Asset Management Inc. now owns 434,514 shares of the company’s stock valued at $31,328,000 after acquiring an additional 3,227 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

PBH has been the topic of several research analyst reports. DA Davidson lifted their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Oppenheimer lifted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research report on Monday, December 9th. Finally, Canaccord Genuity Group upped their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $92.60.

Prestige Consumer Healthcare Stock Down 0.1 %

Shares of Prestige Consumer Healthcare stock opened at $84.66 on Friday. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 19.83, a P/E/G ratio of 2.69 and a beta of 0.50. The stock has a 50-day simple moving average of $79.47 and a 200-day simple moving average of $76.56. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $88.36. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.